Valuation: Elekta AB (publ)

Market Cap 17.81B 1.84B 1.61B 1.49B 1.37B 2.58B 177B 2.63B 6.98B 86.72B 6.9B 6.75B 299B P/E 2027 *
12.5x
P/E 2028 * 11.1x
Enterprise Value 21.29B 2.2B 1.93B 1.78B 1.64B 3.09B 212B 3.14B 8.35B 104B 8.25B 8.07B 357B EV / Sales 2027 *
1.23x
EV / Sales 2028 * 1.15x
Free-Float
94.03%
Yield 2027 *
5.37%
Yield 2028 * 5.92%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 2025-08-31
Director of Finance/CFO - 2026-02-28
Investor Relations Contact - 2023-11-30
Director TitleAgeSince
Director/Board Member 69 2010-06-29
Director/Board Member 70 2011-09-14
Chairman 74 2013-09-02
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 1.86B
-1.17%-0.43%+26.88%-2.24% 198B
-1.33%+0.47%+5.82%-17.71% 144B
+2.24%-13.25%-31.90%+1.58% 122B
-0.59%-1.97%-57.77%-18.13% 65.44B
-0.85%-7.40%+11.13%-8.26% 49.36B
+0.65%-0.59%-23.34%-31.15% 44.74B
-0.91%-2.82%+14.27%+4.58% 37.13B
-3.10%-4.20%+24.35%+27.80% 36.23B
-0.19%+0.06%-23.00%-9.43% 28.7B
Average -0.77%-3.21%-5.95%-5.88% 80.68B
Weighted average by Cap. -1.08%-2.91%-1.75%-6.73%

Financials

2027 *2028 *
Net sales 17.35B 1.79B 1.57B 1.45B 1.33B 2.52B 173B 2.56B 6.8B 84.48B 6.72B 6.58B 291B 18.1B 1.87B 1.64B 1.51B 1.39B 2.63B 180B 2.67B 7.1B 88.17B 7.02B 6.86B 304B
Net income 1.43B 147M 129M 119M 110M 207M 14.2B 210M 559M 6.95B 553M 541M 23.93B 1.61B 166M 145M 134M 123M 233M 15.98B 237M 629M 7.82B 622M 609M 26.94B
Net Debt 3.48B 360M 315M 291M 268M 506M 34.67B 514M 1.37B 16.96B 1.35B 1.32B 58.45B 3B 310M 272M 251M 231M 436M 29.91B 443M 1.18B 14.63B 1.16B 1.14B 50.42B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-